Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • Our Companies
  • left
    • About Us
    • Our Companies
    • Sustainability & Impact
  • Fund
    • Our Investment Strategy
    • Our Investors
    • Our Funds
  • Support
    • Our Value Creation Approach
    • Our Team and Network
  • Return
    • Return to Investors
    • Return to People
    • Return to Society
  • right
    • News
    • JOIN OUR TEAM
    • Investor Portal
    • Contact

NEWS

Our Latest News

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

Global private equity healthcare specialist ARCHIMED further expands its presence in the Consumer Health sector with the acquisition of Groupe Laboratoire Rivadis.

ARCHIMED acquires Groupe Laboratoire Rivadis, a leading player in baby and elderly skincare products

ARCHIMED buys CARSO, a leader in purity testing for pharma and other industries

 December

 16, 

2021

ARCHIMED reaches agreement to sell Bomi Group to UPS

 December

 16, 

2021

ARCHIMED buys a majority stake in SUANFARMA a leading manufacturer and distributor of active pharmaceutical and nutraceutical ingredients

 November

 18, 

2021

ARCHIMED buys Cardioline, Europe’s leader in cardiology-focused telemedicine

 November

 17, 

2021

ARCHIMED buys Cube, an innovative provider of membrane protein services for the biopharma research market

 November

 3, 

2021

ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders

 October

 20, 

2021

< 1 … 5 6 7 8 9 … 17 >
368
  • ARCHIMED © 2025
  • Our Eco-Design Approach
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
  • Manage your cookies
  • .
    Go top

    Back to top